Press Releases

CARLSBAD, Calif., Nov. 6, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the third quarter and year-to-date 2019 and recent business highlights.

REHOVOT, Israel, Nov. 6, 2019 /PRNewswire/ -- Canonic, a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) focused on the development of medical cannabis products, announces today the initiation of its cultivation and breeding program of cannabis varieties with unique genomic profiles for the development of medical cannabis products. The ini

ALPHARETTA, Ga., Nov. 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Crawford, vice president of investor relations, will present at the Stephens Nashville Investment Conference at the Omni Nashville hotel in Nashville, TN on Wednesday, Nov. 13

AUSTIN, Texas, Nov. 6, 2019 /PRNewswire/ -- Beginning Nov. 1 through Dec. 15, Ambetter from Superior HealthPlan wil

TROY, Mich., Nov. 6, 2019 /PRNewswire/ -- Michigan Complete Health is pleased to share the Michigan Department of Health and Human Services (MDHHS) press release dated October 23, 2019, titled

ST. LOUIS, Nov. 6. 2019 /PRNewswire/ -- Home State Health announces a partnership with the National Council on Aging (NCOA) to help prevent falls among Medicare Advantage beneficiaries.Falls are a leading cause of injury for people aged 65 and older and can threaten their safety and independence, as well as generate great economic and personal hardships. Howe

MINNEAPOLIS, Nov. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, today announced the signing of an agreement with C4 Therapeutics, Inc. to acquire an exclusive license for the Achilles-TAG (aTAG) degradation platform. The license

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Polynoma LLC, a U.S. immuno-oncology focused biopharmaceutical company and wholly-owned subsidiary of Hong Kong-listed CK

SEATTLE and VANCOUVER, British Columbia, Nov. 6, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today provided an update on the cytisinicline clinical devel

WOONSOCKET, R.I., Nov. 6, 2019 /PRNewswire/ --Third Quarter Year-over-Year Highlights:Total revenues increased 36.5% to $64.8 billion GAAP operating income increased 13.8% to $2.9 billion Adjusted operating income (1) increased 48.9% to